Michelle H. Cameron
Dr. Michelle Cameron is a neurologist and a physical therapist. She combines her rehabilitation and neurology expertise in treating patients with multiple sclerosis (MS), doing research on fall and mobility in people living with MS and, most recently, providing education and consultation on medical uses of cannabis and cannabinoids.
MY LATEST PUBLICATIONS & PRESENTATIONS
Rice J, Cameron MH. Cannabinoids for treatment of MS symptoms: State of the evidence. Current Neurology and Neuroscience Reports. 2018 Jun 19; 18(8):50.
Martini DN, Zeeboer E, Hildebrand A, Fling BW, Hugos CL, Cameron MH. ADSTEP: Preliminary investigation of a multicomponent walking aid program in people with multiple sclerosis. Archives of Physical Medicine and Rehabilitation, 2018, 99(10):2050-2058.
Hugos CL, Cameron MH, Chen Z, Chen Y, Bourdette D. A multicenter randomized controlled trial of two group education programs for fatigue in multiple sclerosis: Long-term (12 month) follow-up at one site. Multiple Sclerosis Journal. 2018, May 1:1352458518775920.
Loy BD, Cameron MH, O’Connor PJ. Perceived fatigue and energy are independent unipolar states: Supporting evidence. Medical Hypotheses. 2018, 113:46.-51.
Spain R, Powers K, Murchison C, Heriza E, Winges K, Yadav V, Cameron MH, et al. Lipoic acid in secondary progressive multiple sclerosis: a randomized controlled pilot trial. Neurology: Neuroimmunology & Neuroinflammation. 2017, 4(5):e374.
Cameron MH, McMillan G. Methylphenidate is likely less effective than placebo for improving imbalance, walking and fatigue in people with multiple sclerosis. Multiple Sclerosis Journal. 2017, 3(1):1-11.
Cameron M. H. Physical Agents in Rehabilitation: An Evidence-Based Approach to Practice. Philadelphia, PA: W. B. Saunders Company. 5th edition 2017, now also available in Spanish
Medical cannabis November 2018
Panel discussion, Greater Portland Inc., Portland, OR
Cannabinoids in MS November 2018
Presentation for the Society of Clinical Research Associates, Portland, OR
Comparing “gold standard” prospective daily self-report fall calendars with a real-time body-worn self-report device in multiple sclerosis
Hildebrand A, Jacobs P, Folsom J, Leitschuh J, Mosquera-Lopez C, Oganessian S, Wan E, Cameron M October 2018
Poster at European Committee for Treatment and Research in Multiple Sclerosis, Berlin, Germany
Physical agents in rehabilitation
Presentation for Physical Medicine & Rehabilitation Department, Tartu University, Tartu, Estonia October 2018
Presentation for Physical Therapy Department, University of Queretaro, Mexico December 2018
Updates in MS rehabilitation
Presentation for Physical Medicine and Rehabilitation Department, Tartu University, Tartu, Estonia October 2018
Clinical cannabis for the health care provider: Best practices March & September 2018
Program co-chair and presenter
Hot topics in MS – Cannabinoids and Gut Microbiome
Cameron MH, Sand IK September 2018
Webinar for people with MS through Can Do MS
Clinical cannabis and pain management
Cameron M, Jones KD
Presentation for North West Pain Center, VA Portland Health Care Service August 2018
Presentation for Legacy Emmanuel Hospital, Portland, OR November 2018
Symptom Management in MS: Management of Ambulatory Dysfunction in MS April 2018
Presentation at American Academy of Neurology annual meeting, Los Angeles, CA
Evaluation of a spasticity management program for people with multiple sclerosis: Full-scale study protocol
Hugos C, Cameron M
Poster at American Academy of Neurology annual meeting, Los Angeles, CA April 2018
Poster at Consortium for MS Centers annual meeting, Nashville, TN May 2018